Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 8 studies | 29% ± 16% | |
| ciliated cell | 7 studies | 43% ± 23% | |
| acinar cell | 3 studies | 43% ± 25% | |
| ependymal cell | 3 studies | 55% ± 18% |
Insufficient scRNA-seq data for expression of SERPINI2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 74.49 | 2559 / 2642 | 62% | 1.98 | 434 / 705 |
| pancreas | 100% | 19841.21 | 328 / 328 | 42% | 18.73 | 75 / 178 |
| lung | 90% | 75.63 | 521 / 578 | 11% | 0.30 | 128 / 1155 |
| esophagus | 72% | 21.11 | 1043 / 1445 | 3% | 0.07 | 5 / 183 |
| spleen | 74% | 20.06 | 178 / 241 | 0% | 0 | 0 / 0 |
| prostate | 67% | 20.44 | 164 / 245 | 1% | 0.01 | 3 / 502 |
| kidney | 65% | 13.16 | 58 / 89 | 0% | 0.00 | 3 / 901 |
| heart | 54% | 24.35 | 466 / 861 | 0% | 0 | 0 / 0 |
| ovary | 19% | 2.73 | 34 / 180 | 34% | 3.67 | 145 / 430 |
| intestine | 36% | 7.45 | 349 / 966 | 2% | 0.61 | 9 / 527 |
| uterus | 21% | 15.68 | 36 / 170 | 11% | 1.42 | 50 / 459 |
| thymus | 27% | 4.74 | 177 / 653 | 0% | 0.01 | 2 / 605 |
| breast | 22% | 6.79 | 102 / 459 | 2% | 0.03 | 17 / 1118 |
| adipose | 24% | 9.37 | 283 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 19% | 5.37 | 254 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 18% | 0.48 | 8 / 45 |
| stomach | 14% | 3.32 | 49 / 359 | 2% | 0.06 | 5 / 286 |
| bladder | 10% | 4.29 | 2 / 21 | 1% | 0.02 | 4 / 504 |
| adrenal gland | 5% | 0.71 | 12 / 258 | 3% | 0.31 | 8 / 230 |
| peripheral blood | 7% | 1.20 | 65 / 929 | 0% | 0 | 0 / 0 |
| liver | 5% | 0.82 | 12 / 226 | 1% | 0.04 | 4 / 406 |
| skin | 4% | 0.85 | 74 / 1809 | 1% | 0.04 | 4 / 472 |
| muscle | 5% | 0.58 | 37 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010951 | Biological process | negative regulation of endopeptidase activity |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SERPINI2 |
| Protein name | Serpin I2 (Myoepithelium-derived serine protease inhibitor) (Pancpin) (Pancreas-specific protein TSA2004) (Peptidase inhibitor 14) (PI-14) Serpin family I member 2 |
| Synonyms | MEPI PI14 |
| Description | |
| Accessions | ENST00000466903.1 ENST00000461846.5 C9J7N5 A0A8V8PL11 O75830 ENST00000471111.5 ENST00000476257.6 C9JWE1 ENST00000467583.1 ENST00000264677.9 |